Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma (Q33384029)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q28317101)
(Q41784107)
(Q49880375)
(Q32649390)
(Q107526958)
(Q32649861)
(Q115360311)
(P304) 2823-2830
(P407) (Q1860)
(P433) 17
(P478) 27
(P577) Monday, April 6, 2009
(P921) (Q269829)
(Q423762)
(Q415588)
(P1433) (Q400292)
(P1476) "Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma" (language: en)
(P2093) Sanjiv S Agarwala
Uwe Trefzer
David Hogg
Peter Hersey
Stephan Grabbe
Rene Gonzalez
Christian Peschel
Claus Garbe
Steven O'Day
J Michael White
Chenghua Xia
Kiran Patel
John M Kirkwood
other details
description scientific article

External Links